Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose dutasteride effectively and safely promotes hair growth in men.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

PLD is an effective and safer alternative for treating breast cancer.

Docetaxel is effective against various cancers but mainly causes neutropenia.

AS101 reduces hair loss from chemotherapy.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

DPK-060 in poloxamer gel effectively treats skin infections, but nanocarriers don't enhance its efficacy.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

Bimatoprost is a safe and effective treatment for making eyelashes longer, thicker, and darker.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The treatment was ineffective in humans.

Topical finasteride might help with male hair loss with fewer side effects than pills, but more research is needed.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

The food supplement with L-cystine, Serenoa repens extract, and biotin safely reduced hair loss and improved hair growth in men and women.